Direct estimates of human per nucleotide mutation rates at 20 loci causing Mendelian diseases

被引:246
作者
Kondrashov, AS [1 ]
机构
[1] Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20892 USA
关键词
mutation rate; human; target size; hot spot; mutation analysis;
D O I
10.1002/humu.10147
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
I estimate per nucleotide rates of spontaneous mutations of different kinds in human's directly from the data on per locus mutation. rates and on sequences of de novo nonsense nucleotide substitutions, deletions, insertions, and complex events at eight loci causing autosomal dominant diseases and 12 loci causing X-linked diseases. The results are in good agreement with indirect estimates, obtained by Comparison of orthologous human and chimpanzee pseudogenes. The average direct estimate of the combined rate of all mutations is 1.8 x 10(-8) per nucleotide per generation, and the coefficient of variation of this rate across the 20 loci is 0.53. Single nucleotide substitutions are similar to25 times more common than all other mutations, deletions are similar tothree times more common than insertions, complex mutations are very rare, and CpG context increases Substitution rates by an order of magnitude. There is only a moderate tendency for loci with high er locus mutation rates to also have higher per nucleotide substitution rates, and per nucleotide rates of deletions and insertions are statistically independent on the per lotus mutation rate. Rates of different kinds of mutations are strongly correlated Across loci. Mutational hot spots with per nucleotide rates above 5 x 10(-7) make only a minor contribution to human mutation. In the next decade, direct measurements will produce a rather precise, quantitative description Of human spontaneous mutation at the DNA level.
引用
收藏
页码:12 / 27
页数:16
相关论文
共 176 条
  • [11] Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening
    Bezman, L
    Moser, AB
    Raymond, GV
    Rinaldo, P
    Watkins, PA
    Smith, KD
    Kass, NE
    Moser, HW
    [J]. ANNALS OF NEUROLOGY, 2001, 49 (04) : 512 - 517
  • [12] Bezman L, 1998, AM J MED GENET, V76, P415, DOI 10.1002/(SICI)1096-8628(19980413)76:5<415::AID-AJMG9>3.3.CO
  • [13] 2-J
  • [14] BICHET DG, 1994, AM J HUM GENET, V55, P278
  • [15] FAMILIAL ADENOMATOUS POLYPOSIS (FAP) - FREQUENCY, PENETRANCE, AND MUTATION-RATE
    BISGAARD, ML
    FENGER, K
    BULOW, S
    NIEBUHR, E
    MOHR, J
    [J]. HUMAN MUTATION, 1994, 3 (02) : 121 - 125
  • [16] Epidemiology of familial adenomatous polyposis in Sweden:: Changes over time and differences in phenotype between males and females
    Björk, J
    Åkerbrant, H
    Iselius, L
    Alm, T
    Hultcrantz, R
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 (12) : 1230 - 1235
  • [17] Familial adenomatous polyposis (FAP) and its gene, APC
    Bodmer, W
    [J]. CYTOGENETICS AND CELL GENETICS, 1999, 86 (02): : 99 - 104
  • [18] Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants
    Buckley, RH
    Schiff, RI
    Schiff, SE
    Markert, ML
    Williams, LW
    Harville, TO
    Roberts, JL
    Puck, JM
    [J]. JOURNAL OF PEDIATRICS, 1997, 130 (03) : 378 - 387
  • [19] Pax-6 in development and evolution
    Callaerts, P
    Halder, G
    Gehring, WJ
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 1997, 20 : 483 - 532
  • [20] APC mutation and phenotypic spectrum of Singapore familial adenomatous polyposis patients
    Cao, X
    Eu, KW
    Seow-Choen, F
    Zao, Y
    Cheah, PY
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (01) : 42 - 48